Vaxcyte (PCVX) Amortizatization of Intangibles (2021 - 2026)

Vaxcyte (PCVX) has reported Amortizatization of Intangibles for 6 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 36.66% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $12.6 million (down 61.28% YoY), while the FY2025 annual figure was $14.4 million, down 62.71% from the prior year.
• Amortizatization of Intangibles grew to $3.1 million in Q1 2026 per PCVX's latest filing, from $2.8 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $14.6 million in Q3 2023 and bottomed at -$321000.0 in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $5.4 million across 5 years, with a median of $4.5 million in 2025.
• Annual changes were most pronounced in 2022 — Amortizatization of Intangibles tumbled 112.58% — and 2023, when it surged 8268.28%.
• Vaxcyte's Amortizatization of Intangibles stood at $1.2 million in 2022, then soared by 101.62% to $2.4 million in 2023, then jumped by 392.87% to $11.7 million in 2024, then slumped by 76.33% to $2.8 million in 2025, then gained by 12.59% to $3.1 million in 2026.
• Business Quant data shows PCVX's Amortizatization of Intangibles at $3.1 million in Q1 2026, $2.8 million in Q4 2025, and $2.3 million in Q3 2025.